Why users choose GLP1-GO: Works offline Your data stays on your device No account required Multiple unit options (kg, lb, st) Available in English, Greek, French, Spanish, and German Clean, simple design Built for GLP-1 routines Premium Start with a free 7-day trial of premium features, then unlock advanced insights, PDF reports, progress photos, clothing size tracking, weekly wellness check-ins, smart reminders, and unlimited history
These GLP-1 RAs can be contrasted between short-acting (exenatide BID, lixisenatide) and long-acting (daily or weekly) : Short-acting agents (Exenatide BID, Lixisenatide) primarily lower postprandial glucose
Factors Indicating Against Dose Escalation Maintain current dose when experiencing significant side effects at present level, achieving satisfactory subjective improvements (better sleep, energy, recovery), IGF-1 increased adequately (50+ ng/mL) for optimization goals, or financial constraints make higher dosing unsustainable
Manda, G
For patients who measure success by how they look and perform rather than by a number on a scale, this is often a more satisfying outcome